Best 3 Blue Chip Stocks to Buy After a Market Pullback -- Including Microsoft (MSFT) Stock
The article highlights three “blue chip” stocks it says look attractively priced after a market pullback: Microsoft (MSFT), Becton Dickinson (BDX), and Clorox (CLX). It cites MSFT’s forward P/E of 22 and ~0.83% dividend yield; BDX’s forward P/E of 11.7 and ~2.36% yield; and CLX’s forward P/E of 13 and ~5.16% yield, noting oil costs of over $20M quarterly gross profit.
Valuation-focused read-through on MSFT after a market pullback; near-term catalyst is sentiment around AI spending, not a new event.
Article frames MSFT as “more attractively priced” after a ~12% YTD pullback, citing forward P/E ~22 and rising AI capex concerns.
Mildly supportive for dip-buying; limited incremental upside without fresh earnings/guidance.
Background
The article is a long-term “blue chip buy after pullback” list, using current valuation multiples, dividend yields, and select management commentary (for CLX) to argue attractiveness.
Why it matters
No new corporate actions or fresh guidance are disclosed; the main tradable element is sentiment/valuation framing and, for CLX, the stated oil-cost drag and resilience commentary.
Market relevance
Useful for positioning/long-term watchlists, but limited as a catalyst-driven trade because it largely restates valuation and general business narratives.
Market effects
Reinforces defensive rotation themes: large-cap tech valuation (MSFT) and healthcare/consumer staples income defensiveness (BDX, CLX).
Primarily US large-cap sentiment; no explicit regional macro linkage beyond general market pullback framing.
Oil-cost sensitivity highlighted for staples (CLX), indirectly linking to global energy price moves.
Alternative perspectives
These are thesis/opinion-style “best stocks to buy” pieces; without new earnings/guidance, they may not drive follow-through versus technical/positioning flows.
AI capex execution risk for MSFT, competitive/pricing dynamics for BDX devices, and whether oil-cost mitigation is sufficient for CLX margins are not quantified with new data.
Key entities
- companyMicrosoft
Discussed as discounted vs history with AI capex debate and dividend support.
- companyBecton, Dickinson
Presented as defensive medical supplies with recurring demand and low forward P/E.
- companyClorox
Presented as income-oriented staples facing oil-cost headwind and management’s resilience comments.
